Your browser doesn't support javascript.
loading
[Early detection of cancer therapeutics-related cardiac dysfunction]. / Stratégie de dépistage précoce de la toxicité cardiaque secondaire aux anthracyclines et thérapies moléculaires ciblées.
Potier, Agathe; Ederhy, Stéphane; Ancedy, Yann; Etienney, Arnaud; Soulat-Dufour, Laurie; Chauvet, Marion; Hollebecque, Antoine; Adavane-Scheuble, Saroumadi; Boccara, Franck; Soria, Jean-Charles; Cohen, Ariel.
Afiliação
  • Potier A; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
  • Ederhy S; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
  • Ancedy Y; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
  • Etienney A; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
  • Soulat-Dufour L; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
  • Chauvet M; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
  • Hollebecque A; DITEP, Gustave-Roussy Cancer Campus, France.
  • Adavane-Scheuble S; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
  • Boccara F; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France.
  • Soria JC; DITEP, Gustave-Roussy Cancer Campus, France.
  • Cohen A; AP-HP, université Pierre-et-Marie-Curie, hôpitaux de l'Est parisien (Saint-Antoine-Tenon), service de cardiologie, Paris-Sorbonne, 184, rue du Faubourg-Saint-Antoine, 75571 Paris cedex 12, France; Unité INSERM 856 «Thrombose, athérothrombose et pharmacologie appliquée¼, 75013 Paris, France. Electron
Bull Cancer ; 103(7-8): 667-73, 2016.
Article em Fr | MEDLINE | ID: mdl-27417336
Anthracyclines and molecular targeted agents have improved prognosis of patients undergoing chemotherapeutics for malignancy. However, the use of these therapies is limited because of risk of cardiac toxicity. The severity of the cardiomyopathy can range from an asymptomatic left ventricular (LV) dysfunction to a severe congestive heart failure. Cardiomyopathy can be reversible or irreversible according to the type of chemotherapy, modality of administration and patient's characteristics. Several studies aimed to early detection and the evaluation of tools to characterize patients at risk to develop cardiac side effects in order to prevent severe LV dysfunction. According to this literature, it is recommended that initial assessment and follow-up of patients undergoing these chemotherapies be performed using troponin dosage, assessment of left ventricle ejection fraction and evaluation of LV myocardial deformation assessing LV global longitudinal strain.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antraciclinas / Cardiopatias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: Fr Revista: Bull Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França País de publicação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antraciclinas / Cardiopatias Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: Fr Revista: Bull Cancer Ano de publicação: 2016 Tipo de documento: Article País de afiliação: França País de publicação: França